CVRx
CVRX
55 hedge funds and large institutions have $72.3M invested in CVRx in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 13 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 14
2% more funds holding
Funds holding: 54 → 55 (+1)
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
4.37% less ownership
Funds ownership: 63.32% → 58.95% (-4.4%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
54% less capital invested
Capital invested by funds: $158M → $72.3M (-$85.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.33M |
| 2 |
PGM
Parian Global Management
Pound Ridge,
New York
|
+$1.22M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$563K |
| 4 |
D.E. Shaw & Co
New York
|
+$481K |
| 5 |
Walleye Capital
New York
|
+$379K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$8.84M |
| 2 |
VA
VR Adviser
New York
|
-$6.52M |
| 3 |
Man Group
London,
United Kingdom
|
-$892K |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$736K |
| 5 |
RCM
Revelation Capital Management
Sausalito,
California
|
-$467K |
CVRX Hedge Fund Activity: Q1 2022 in Review
55 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in CVRx (CVRX) for Q1 2022, worth a combined $72.3M — down 54% from $158M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new CVRX positions and 13 closed out — a net gain of 1 holder — while 16 added to existing stakes and 14 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $1.33M. The largest seller was OrbiMed, exiting entirely with an estimated $8.84M sold.
- 55 institutional investors held CVRx (CVRX) as of Q1 2022, up from 54 in Q4 2021.
- Funds reported $72.3M of CVRx stock for Q1 2022, down 54% quarter-over-quarter.
- 14 funds opened new CVRx positions in Q1 2022 and 13 closed out, a net change of +1 holder.
- The largest CVRx buyer in Q1 2022 was Renaissance Technologies, an estimated $1.33M added.
- The largest CVRx seller in Q1 2022 was OrbiMed, an estimated $8.84M sold.
Based on aggregated 13F filings for Q1 2022.